Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-13 Sale | 2022-06-14 8:37 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 2,700 | $9.4789 | $25,593 | 6,515 (Direct) | View |
| 2022-06-02 Sale | 2022-06-03 4:31 pm | Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director | 6,441 | $9.902 | $63,779 | 63,064 (Direct) | View |
| 2022-05-31 Sale | 2022-06-02 4:47 pm | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 6,500 | $9.8542 | $64,052 | 68,387 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:29 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 12,060 | $11.09 | $133,779 | 181,351 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:28 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer | 6,974 | $11.19 | $78,060 | 177,778 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:27 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 37,096 | $11.16 | $413,959 | 1,627,766 (Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:27 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick CFO | 12,305 | $11.26 | $138,513 | 197,826 (Indirect Direct) | View |
| 2022-02-28 Sale | 2022-03-02 9:26 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP | 15,601 | $11.25 | $175,492 | 266,307 (Direct) | View |
| 2021-11-30 Sale | 2021-12-02 4:31 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 96,200 | $16.25 | $1,563,623 | 1,346,538 (Direct) | View |
| 2021-09-15 Sale | 2021-09-17 08:52 am | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 16,824 | $16.49 | $277,394 | 162,362 (Direct) | View |
| 2021-09-09 Sale | 2021-09-13 4:40 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 19,109 | $16.74 | $319,976 | 31,091 (Direct) | View |
| 2021-08-20 Sale | 2021-08-23 4:36 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer | 3,650 | $15.39 | $56,190 | 74,552 (Direct) | View |
| 2021-08-16 Sale | 2021-08-17 4:31 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 3,715 | $16.15 | $59,989 | 83,211 (Direct) | View |
| 2021-07-28 Sale | 2021-07-30 09:15 am | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick CFO | 2,130 | $19.24 | $40,973 | 99,931 (Indirect Direct) | View |
| 2021-07-26 Sale | 2021-07-27 4:37 pm | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 7,250 | $19.69 | $142,776 | 86,685 (Direct) | View |
| 2021-06-15 Sale | 2021-06-17 5:01 pm | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,000 | $19.42 | $97,122 | 15,200 (Direct) | View |
| 2021-06-14 Sale | 2021-06-15 4:42 pm | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 2,075 | $19.34 | $40,132 | 12,925 (Direct) | View |
| 2021-03-15 Sale | 2021-03-16 4:20 pm | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 18,000 | $17.72 | $319,010 | 148,935 (Direct) | View |
| 2021-03-08 Sale | 2021-03-09 5:15 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 175,000 | $18 | $3,150,053 | 1,221,062 (Direct) | View |
| 2021-03-05 Sale | 2021-03-08 5:47 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 5,600 | $17.85 | $99,966 | 86,926 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:43 pm | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 19,530 | $18.58 | $362,850 | 92,526 (Direct) | View |
| 2021-03-02 Sale | 2021-03-03 6:42 pm | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer | 3,888 | $18.45 | $71,729 | 78,202 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:41 pm | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 22,685 | $18.38 | $416,905 | 1,396,062 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:40 pm | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick CFO | 9,371 | $18.35 | $171,971 | 102,061 (Indirect Direct) | View |
| 2021-03-02 Sale | 2021-03-03 6:40 pm | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 3,865 | $18.04 | $69,717 | 96,935 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 6:39 pm | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP | 20,465 | $18.28 | $374,017 | 171,708 (Direct) | View |
| 2021-02-24 Sale | 2021-02-26 5:17 pm | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 22,986 | $20.01 | $460,033 | 199,501 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-16 Option Award | 2022-06-21 4:55 pm | N/A 2032-06-15 | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 36,713 | $0 | 46,713 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:55 pm | N/A 2032-06-15 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 36,713 | $0 | 43,228 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:54 pm | N/A 2032-06-15 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 36,713 | $0 | 105,100 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:53 pm | N/A 2032-06-15 | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 36,713 | $0 | 49,638 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-03 4:31 pm | N/A 2022-06-13 | Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director | 15,000 | $0 | 63,064 (Direct) | View |
| 2022-06-02 Exercise | 2022-06-03 4:31 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director | 15,000 | $4.15 | 63,064 (Direct) | View |
| 2022-05-31 Exercise | 2022-06-02 4:47 pm | N/A 2022-06-13 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 15,000 | $0 | 68,387 (Direct) | View |
| 2022-05-31 Exercise | 2022-06-02 4:47 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 15,000 | $4.15 | 68,387 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:29 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 110,200 | $0 | 181,351 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:28 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer | 110,200 | $0 | 177,778 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:27 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 390,000 | $0 | 1,627,766 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:27 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick CFO | 110,200 | $0 | 197,826 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-02 9:26 pm | N/A 2032-02-27 | Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther VP | 110,200 | $0 | 266,307 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 4:31 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 150,000 | $4.88 | 1,346,538 (Direct) | View |
| 2021-11-30 Exercise | 2021-12-02 4:31 pm | N/A 2021-12-05 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 150,000 | $0 | 1,346,538 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 08:52 am | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 4,277 | $12.27 | 162,362 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 08:52 am | N/A 2029-07-24 | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 12,119 | $0 | 162,362 (Direct) | View |
| 2021-09-15 Exercise | 2021-09-17 08:52 am | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 7,842 | $11.32 | 162,362 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A 2030-06-10 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 19,109 | $0 | 31,091 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 5,985 | $10.57 | 31,091 (Direct) | View |
| 2021-09-09 Exercise | 2021-09-13 4:40 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 13,124 | $12.7 | 31,091 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 5:01 pm | N/A 2030-06-10 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 4,015 | $0 | 15,200 (Direct) | View |
| 2021-06-15 Exercise | 2021-06-17 5:01 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 4,015 | $10.57 | 15,200 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:37 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | Watkins Thomas Director | 15,000 | $0 | 64,505 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:36 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director | 15,000 | $0 | 20,000 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:36 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director | 15,000 | $0 | 20,200 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:35 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director | 15,000 | $0 | 69,887 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 4:34 pm | N/A 2031-06-09 | Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director | 15,000 | $0 | 25,000 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-16 4:20 pm | N/A 2030-02-25 | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 15,000 | $0 | 148,935 (Direct) | View |
| 2021-03-15 Exercise | 2021-03-16 4:20 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 15,000 | $11.32 | 148,935 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:19 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy VP | 110,200 | $0 | 189,556 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:19 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP Chief Marketing Officer | 87,000 | $0 | 143,290 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:18 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos CEO | 390,000 | $0 | 1,693,747 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:17 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick CFO | 110,200 | $0 | 188,932 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 5:17 pm | N/A N/A | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 22,499 | $12.27 | 199,501 (Direct) | View |
| 2021-02-24 Option Award | 2021-02-26 5:17 pm | N/A 2031-02-23 | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 87,000 | $0 | 199,501 (Direct) | View |
| 2021-02-24 Exercise | 2021-02-26 5:17 pm | N/A 2029-07-24 | Vanda Pharmaceuticals Inc. | VNDA | Jones Aranthan II Chief Corp. Affairs Officer | 22,499 | $0 | 199,501 (Direct) | View |